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Introduction
Mitochondria are responsible for aerobic respiration and ATP 
synthesis by oxidative phosphorylation. In addition to being 
crucial for energy production and metabolic pathways, they 
also play key roles in integrating cell death stimuli and exe-
cuting the apoptotic program. Apoptosis plays an important 
role in development, morphogenesis, tissue remodeling, and 
diseases such as cancer and neurodegeneration. In the classi-
cal mitochondria-initiated apoptotic pathway, permeabiliza-
tion of the mitochondrial outer membrane leads to cytochrome c 
release into the cytosol, formation of the apoptosome, and 
the subsequent activation of the caspase cascade (Spierings 
et al., 2005).
Another intracellular pathway of cell death involves ER 
stress. The ER is involved in the synthesis, folding, and modifi  -
cation of cell surface and secretory proteins, and is a key site 
for intracellular calcium storage. Disruption of these func-
tions leads to the activation of the unfolded protein response. 
  Prolonged ER stress can lead to the accumulation of misfolded 
proteins, inhibition of protein glycosylation, and disruption of 
calcium homeostasis, which results in apoptosis (Xu et al., 
2005). Although the mechanisms are still unclear, it is evident 
that ER stress engages the mitochondrial apoptotic pathways 
(Li et al., 2006).
Respiratory chain (RC) dysfunction is associated with 
mitochondrial diseases that affect tissues with high-energy de-
mands such as brain, skeletal muscle, and heart (DiMauro and 
Schon, 2003). RC dysfunction has also been associated with 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s 
disease (Kwong et al., 2006). The biogenesis of the mitochon-
drial RC is especially complex, as it is under the control of both 
the nuclear and mitochondrial genomes. The mitochondrial 
DNA (mtDNA) encodes for 13 polypeptides, all of which are 
integral subunits of the RC complexes (Anderson et al., 1981). 
Mutations in the mtDNA cause RC defects in some forms of 
mitochondrial disorders (DiMauro and Schon, 2003) but have 
also been shown to accumulate in normal aging (Kujoth et al., 
2006) and in cancer (Polyak et al., 1998; Chatterjee et al., 
2006). In the case of neurodegeneration and aging, it has been 
hypothesized that mtDNA mutations cause RC distress, which 
leads to mitochondrial dysfunction and apoptosis, whereas, 
in the case of cancer, RC dysfunction may confer resistance 
to apoptotic cell death. Therefore, dysregulation of apopto-
sis could be the link between RC defects and these divergent 
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pathophysiological extremes, but the mechanisms whereby the 
RC regulates apoptosis remain to be elucidated. 
Here, we investigated the role of RC defects in regulating 
apoptotic cell death. We wanted to determine whether or not 
the effects of RC dysfunction on apoptosis varied depending 
on the loss of specifi  c enzymatic activities. We used transmito-
chondrial cybrid cells harboring pathogenic mtDNA mutations 
as genetic tools to study targeted disruption of RC complexes. 
We compared the effects of a panel of diverse mtDNA muta-
tions affecting different components of the RC on two different 
intracellu  lar pathways of apoptosis. We focused on the mito-
chondria-initiated and the ER stress–induced pathways, because 
mitochondria and ER cooperate to form a functionally integrated 
system to maintain cellular homeostasis. We show that, although 
all the mtDNA mutations caused reduced mitochondrial respira-
tion and ATP synthesis, they exhibited vastly different patterns 
of responses to mitochondrial and ER stress–mediated apoptotic 
stimuli. We identify the RC electron fl  ux as a key modulator 
of apoptosis.
Results
MtDNA mutant cybrid cell lines
In this study, we used human osteosarcoma cybrid cells to examine 
different pathogenic mtDNA mutations against a common nuclear 
background. Cybrids were derived from the fusion of 143B ρ
0 
cells, which are cells devoid of mtDNA, with enucleated cells 
from patients with mtDNA mutations (King and Attardi, 1989). 
All cybrid cell lines harbored homoplasmic levels of mutant 
mtDNA (i.e., 100% mutant).
The mutations we studied can be placed into three cate-
gories. The fi  rst consists of two mutations that affect single 
RC complexes, resulting in their disassembly and complete 
loss of function. It includes a stop-codon mutation at mtDNA 
nt 6930 in subunit I of complex IV (cytochrome c oxidase 
[COX]; Fig. 1 A), associated with mitochondrial encephalo-
pathy (Bruno et al., 1999), and a 4–base pair microdeletion 
starting at position 14787 in the cytochrome b subunit of com-
plex III (CYTB), associated with a form of parkinsonism and   
Figure 1.  Characterization of the mtDNA mutant cell 
lines. (A) Schematic representation of the human mtDNA. 
The mutants used in this study are indicated. (B) Coupled 
and uncoupled KCN-sensitive oxygen consumption was 
measured in whole cells with 1 mM pyruvate as a sub-
strate. Cells were uncoupled with the addition of 1 μM 
FCCP. Cells harboring mtDNA mutations have severely 
reduced coupled and uncoupled respiration (n = 6; error 
bars represent SD).THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1165
encephalopathy (De Coo et al., 1999). The second category 
includes a T–G transversion at position 8993 in the ATPase 6 
gene (Holt et al., 1990), associated with neuropathy, ataxia, 
and retinitis pigmentosa (NARP). Unlike the other two protein-
coding gene mutations, NARP affects complex V (F1F0 ATP 
synthase) function, but the protein complex itself is preserved 
(Cortes-Hernandez et al., 2007). The third category includes a 
point mutation at nt 8344 in the tRNA lysine gene (Wallace 
et al., 1988), which affects mtDNA protein synthesis resulting 
in a global loss of all RC complexes. This mutation is associ-
ated with a disease characterized by myoclonic epilepsy with 
ragged red fi  bers (MERRF). In addition, we studied parental 
143B human osteosarcoma cells containing wild-type (WT) 
mtDNA and 143B ρ
0 cells (Table I).
Characterization of respiratory function in 
mtDNA mutants
To characterize the function of the RC in the various cybrid 
cell lines, we measured cyanide-sensitive oxygen consump-
tion under both coupled (phosphorylating) and uncoupled (non-
phosphorylating) states. As expected, ρ
0, COX, CYTB, and 
MERRF mutants had no respiration (Fig. 1 B), which is consis-
tent with a complete blockage of RC electron transfer resulting 
from loss of RC complexes (D’Aurelio et al., 2006). NARP mu-
tants had a partial impairment, with an  50% residual oxygen 
consumption as compared with WT. It was previously shown 
that the NARP mutation affects the ATPase complex and causes 
severely decreased ATP synthesis, resulting in a partial inhibition 
of RC activity (Fig. 1 B) and enhanced free radical production 
(Mattiazzi et al., 2004).
Mutant cybrids have different responses to 
apoptotic stimuli
Intrinsic apoptosis may be initiated through different cellu-
lar pathways that converge upon mitochondria. We set out to 
defi  ne the role that the RC and mtDNA mutations play in apop-
tosis, focusing on the mitochondria-initiated and the ER stress–
induced pathways.
To engage the mitochondrial apoptotic pathway, we used 
staurosporine (STS) or etoposide (ET). As a quantitative measure 
of apoptosis, a caspase 3 fl  uorogenic assay was used. Treatment 
with STS resulted in reduced caspase 3 activation in ρ
0, COX, 
CYTB, and MERRF cybrids as compared with WT (Fig. 2 A). 
Interestingly, NARP cells had increased caspase 3 activation, 
suggesting that mtDNA mutations affecting the ATPase com-
plex behave differently than those affecting the RC. The pattern 
of apoptotic response to STS was confi  rmed by staining for 
apoptotic nuclei (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200704059/DC1). ET showed a pattern of apop-
tosis very similar to STS, although the trend for reduced re-
sponse did not reach statistical signifi  cance in the COX cybrids 
(Fig. 2 B). As expected, ET treatment resulted in cleavage of 
caspases 9 and 3, as detected by Western blot, supporting the 
fi  ndings of the fl  uorogenic assays (Fig. S2 A).
Treatment with thapsigargin (TG) to activate the ER stress 
pathways of apoptosis by inhibiting the sarcoplasmic reticulum/
ER Ca
2+ ATPase showed a remarkably different pattern of cas-
pase 3 activation. Although ρ
0 and MERRF cells were protected, 
COX, CYTB, and NARP had increased caspase 3 activation 
(Fig. 2 C). These results were confi  rmed by annexin V and prop-
idium iodide staining (Fig. S1 B). TG treatment also resulted in 
cleavage of caspases 9 and 3 (Fig. S2 B). A pattern of response 
similar to that of TG was observed using tunicamycin (TN), 
which induces the ER stress response through a different mech-
anism by inhibiting protein glycosylation (Fig. 2 D).
To confi  rm that the pathways leading to cell death in our 
cybrid cells were indeed dependent on caspase activation, we mea-
sured cell survival after treatment with proapoptotic compounds, 
with or without the addition of the pan-caspase inhibitor ZVAD-
fl  uoromethylketone in one of the mutant cell lines. As expected, 
STS, TG, and ET reduced cell viability, as determined by the 
WST-1 live cell assay, and ZVAD-fl  uoromethylketone completely 
prevented cell death (Fig. S2 C).
To discount the possibility that the effects we saw in re-
sponse to TG could be specifi  c to individual cybrid clones, we con-
fi  rmed the results in rederived new MERRF cybrid mass cultures, 
obtained by fusion of enucleated MERRF cells with osteosarcoma 
ρ
0 cells, and in two additional NARP clones (Fig. S3, avail  able 
at http://www.jcb.org/cgi/content/full/jcb.200704059/DC1). 
Furthermore, to exclude the idea that the protection against TG 
in ρ
0 and MERRF mutants was specifi  c to osteosarcoma cells, we 
confi  rmed the results in ρ
0 (Fig. S3 B) and MERRF mutants (not 
depicted) generated in a HeLa nuclear background.
Collectively, these results indicate that the various catego-
ries of mtDNA mutations display clear differences in their re-
sponses to proapoptotic stimuli and that even within the same 
category of mutation, the apoptotic response varies depending 
on the type of stimulus.
Correlation between the mitochondrial 
energetic state and STS-induced apoptosis
We noted that cybrid cell lines harboring mtDNA mutations   
that disrupted mitochondrial respiration were protected against 
STS-induced apoptosis. Therefore, we hypothesized that the 
Table I. Characteristics of the mtDNA mutant cybrid cell lines used in this study
Cell lines RC complexes affected MtDNA gene mutated Nucleotide position of the mutation Reference
ρ
0 I, III, IV, and V No mtDNA NA King and Attardi, 1989
COX IV Cytochrome c oxidase subunit I 6390 Bruno et al., 1999
CYTB III Cytochrome b ∆14787–14790 De Coo et al., 1999
MERRF I, III, IV, and V tRNA lysine 8344 Wallace et al., 1988
NARP V ATPase 6 8993 Holt et al., 1990JCB • VOLUME 179 • NUMBER 6 • 2007  1166
mitochondrial energetic state may be a key regulator of this 
apoptotic pathway. To examine this hypothesis, we studied the 
ability of mutant mitochondria to generate membrane potential 
(∆Ψm) using their RC. As expected, NARP mitochondria, which 
possess all of the RC complexes, generated ∆Ψm (Fig. 3 A), 
albeit at a lower capacity than WT, which is consistent with a 
reduction in respiration (Fig. 1 B). All of the other mutants were 
unable to generate ∆Ψm, which is consistent with a complete 
block in electron transport (Fig. 1 B).
Cells with fragmented mitochondria are 
protected against STS-induced apoptosis
It has been shown that loss of ∆Ψm results in a fragmentation of 
the mitochondrial network (Legros et al., 2002) and that ρ
0 cells 
have altered mitochondrial morphology (Gilkerson et al., 2000). 
In our mutant cybrids, confocal microscopy of cells stained with 
the mitochondria-specifi  c dye MitoTracker Red revealed a normal 
tubular network in WT and NARP cells, whereas ρ
0, COX, CYTB, 
and MERRF cells had fragmented mitochondria (Fig. 3 C). 
Measurement of mitochondrial length showed that these mutants 
have shorter mitochondria (Fig. 3 D). By arbitrarily categorizing 
mitochondria based on size, WT and NARP cells have an approxi-
mately equal distribution of long (>2 μm) and short (<2 μm) 
mitochondria, whereas ρ
0, COX, CYTB, and MERRF cells have 
almost exclusively short mitochondria (Fig. 3 E). These results 
indicate a strong correlation between the loss of electron transfer 
and the disruption of the mitochondrial network. They also sug-
gest that morphological changes are correlated with the pattern of 
sensitivity to mitochondrial stressors but not that of ER stressors, 
as all cells with fragmented mitochondria were protected against 
STS or ET-induced apoptosis but COX and CYTB cells were 
highly sensitive to TG and TN.
MtDNA mutations do not affect the 
induction of the ER stress–response 
pathway
The response to ER stress–induced cell death did not follow the 
same pattern as that of mitochondrial-induced cell death be-
cause some of the mutants that displayed the highest caspase 
activation (Fig. 2, C and D, COX and CYTB) were protected 
against STS- and ET-induced death (Fig. 2, A and B). To deter-
mine if the differences observed in TG-induced apoptosis were 
caused by differential ER stress responses, we monitored the 
levels of the ER stress marker Grp78 (Li et al., 2006). We found 
that all cell lines up-regulated Grp78 equally after TG treatment 
(Fig. 4). Therefore, we concluded that mtDNA mutations do not 
affect the cell’s ability to mount an ER stress response and that 
this pathway was intact and activated in all cell lines.
Mitochondrial ATP synthesis is not 
required for ER stress–induced apoptosis 
and ER stress does not result in acute 
ATP depletion
Because apoptosis and caspase activation are energy-dependent 
processes, we tested whether defective  mitochondrial ATP pro-
duction plays a role in modulating ER stress– induced apoptosis. 
To completely inhibit mitochondrial ATP synthesis, WT cells 
were treated with the ATP synthase inhibitor oligomycin in 
combination with TG. Oligomycin had no signifi  cant effect on 
TG-induced caspase 3 activation as compared with TG treat-
ment alone (Fig. 5 A). However, it caused increased caspase 3 
activation in ρ
0, COX, CYTB, and MERRF cells. Collectively, 
Figure 2.  Apoptosis in the mtDNA mutant cybrid cells. (A) Caspase 3 ac-
tivity in response to 1 μM STS for 6 h, expressed as a percentage of the 
response observed in WT cells (n = 4; error bars represent SEM). ρ
0, COX, 
CYTB, and MERRF cells are protected, whereas NARP cells are hypersensi-
tive to STS-induced caspase 3 activation. (B) Caspase 3 activity in response 
to 10 μM ET for 24 h, expressed as a percentage of the response ob-
served in WT cells (n = 4; error bars represent SEM). ρ
0, MERRF, COX, 
and CYTB show a trend for protection, whereas NARP cells are hypersensi-
tive to ET-induced caspase 3 activation. (C) Caspase 3 activity in response 
to 1 μM TG for 24 h, expressed as a percentage of the response observed 
in WT cells (n = 8; error bars represent SEM). ρ
0 and MERRF cells were 
protected against TG, whereas COX, CYTB, and NARP cells were hyper-
sensitive to TG. (D) Caspase 3 activity in response to 1 μM TN for 24 h, 
expressed as a percentage of the response observed in WT cells (n = 4; 
error bars represent SEM). The pattern of TN-induced caspase 3 activity 
mirrored the pattern induced by TG (C).THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1167
these results indicate that mitochondrial ATP synthesis is not 
necessary for TG-induced caspase activation and that glycolytic 
ATP is suffi  cient to drive ER stress–induced apoptosis. How-
ever, because oligomycin inhibits both mitochondrial ATP syn-
thesis and hydrolysis and cells lacking RC function may be 
actively consuming ATP in mitochondria, these results also 
suggest that oligomycin may actually increase the pool of ATP 
available for caspase activation in mutant cells.
It has been shown that a transient decrease in cellular ATP 
levels can commit cells to apoptosis (Izyumov et al., 2004). 
To determine the effect of ER stress on cellular steady-state ATP 
levels, ATP content was monitored during TG treatment at time 
Figure 3.  𝖫𝖿m generated by the RC is necessary to maintain normal mitochondrial morphology. (A) Representative traces of the ∆Ψm generated in isolated 
mitochondria from WT and ρ
0 cells. Incubation medium (see Materials and methods) was supplemented with 5 mM succinate (S). 1 μM antimycin A was 
added to deenergize mitochondria (AA). (B) Quantiﬁ  cation of ∆Ψm generated in mtDNA mutant cells (n = 3). Only WT and NARP cells were able to gener-
ate RC-supported ∆Ψm. (C) Confocal images of cells stained with 100 nM MitoTracker Red CMXRos for 30 min at 37°C. WT and NARP cells have intact 
mitochondrial networks, whereas ρ
0, COX, CYTB, and MERRF cells display fragmented and punctate mitochondrial morphology. (D) Mean mitochondrial 
length in the mtDNA mutant cybrids. ρ
0, COX, CYTB, and MERRF mitochondria had signiﬁ  cantly decreased mean lengths as compared with WT and NARP 
mitochondria. 100 mitochondria were scored for each cell line (error bars represent SEM). (E) Distribution of mitochondrial lengths in the various cell lines. 
ρ
0, COX, CYTB, and MERRF cells had a signiﬁ  cant decrease in the proportion of mitochondria >2 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1168
points preceding any appreciable cell death. Over a 3-h period, 
there was no change in ATP content in any of the cell lines 
tested (Fig. 5 B). Therefore, we concluded that acute ATP de-
pletion does not play a role in this mode of cell death and cannot 
explain the different responses in the various mutant cell lines.
Acute mitochondrial uptake of ER Ca
2+ 
released by TG in mutant cybrids
Both the mitochondria and ER cooperate in maintaining intra-
cellular Ca
2+ homeostasis. Acute mitochondrial uptake of Ca
2+ 
released upon ER stress may trigger mitochondrial permeability 
transition and the release of proapototic factors. To test this pos-
sibility, we treated cells with TG and the permeability transition 
pore inhibitor cyclosporine A. Cyclosporine A did not protect 
against TG-induced caspase 3 activation in any of the cell lines 
(unpublished data). Therefore, we concluded that in our model, 
Ca
2+-mediated permeability transition does not play a role in 
ER stress–induced apoptosis.
To further investigate whether differential Ca
2+ uptake 
may play a role in TG sensitivity, we compared the amount of 
Ca
2+ taken up into mitochondria after TG stimulation in the vari-
ous cell lines. Changes in cytosolic Ca
2+ in intact cells were 
monitored using Fura 2AM. First, cytosolic Ca
2+ was measured 
before and after the addition of FCCP to release mitochondrial 
Ca
2+ (Fig. 6 A). The difference in cytosolic Ca
2+ before and after 
carbonylcyanide-p-trifl  uoromethoxyphenylhydrazone (FCCP) 
was taken as a measure of basal mitochondrial Ca
2+ stores (Fig. 
6 A, mCa before). Ca
2+ was then released from the ER using TG, 
followed by release of Ca
2+ from the mitochondria using FCCP 
(Fig. 6 B, mCa after). The difference in cytosolic Ca
2+ levels 
between the two FCCP-induced Ca
2+ peaks (Fig. 6 C) was indica-
tive of the amount of Ca
2+ taken up into the  mitochondria after 
TG stimulation. If acute mitochondrial Ca
2+ uptake was the sig-
nal that triggers the apoptotic response, then one would expect 
that mitochondria from cell lines with normal or increased TG 
sensitivity should be able to take up Ca
2+, whereas mitochondria 
from cells with reduced sensitivity should not. Consistent with 
this hypothesis, we found that ρ
0 and MERRF cells, which are 
protected against TG-induced death, did not take up additional 
Ca
2+ after TG, whereas COX and CYTB cells, which are more 
sensitive to TG, did (Fig. 6 C). However, NARP cells, which also 
have increased sensitivity to TG, were unable to take up Ca
2+. 
Figure 4.  ER stress is induced equally in mtDNA mutant cells. Western blot 
of the ER stress marker Grp78. TG treatment (1 μM for 24 h) strongly 
up-regulated Grp78 protein expression in all cell lines. Tim23, a protein 
unaffected by ER stress, was used as a loading control.
Figure 5.  Mitochondrial ATP synthesis and cellular 
ATP content are not implicated in ER stress–induced 
apoptosis. (A) Caspase 3 activity in cells treated with 
either 1 μM TG alone or 1 μg/ml TG in combination 
with the mitochondrial ATP synthase inhibitor oligo-
mycin for 24 h (n = 6; error bars represent SEM). Inhi-
bition of ATP synthase did not modify the response in 
WT cells, whereas mutant cells exhibited increased 
caspase activity. (B) WT, ρ
0, CYTB, and NARP cells 
were treated with 1 μM TG for various times and total 
cellular ATP content was measured (n = 3; error bars 
represent SEM). ATP content at each time point is ex-
pressed as a percentage of the untreated values, suggest-
ing that acute ER stress does not result in ATP depletion.THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1169
This unexpected result was replicated in another, independent 
NARP cell line derived from a different patient (unpublished 
data), suggesting that in these mutants other factors may contrib-
ute to enhanced sensitivity to ER stress.
Mitochondrial uptake of Ca
2+ depends on ∆Ψm, which can 
be generated either by using the RC or by the reverse action of 
the ATPase complex that hydrolyzes ATP to pump protons from 
the matrix into the intermembrane space. To determine if the dif-
ferences in mitochondrial uptake of Ca
2+ released from the ER 
correlated with bioenergetics, we examined the ability of iso-
lated mitochondria to take up Ca
2+ in the presence of different 
substrates and increasing Ca
2+ concentrations. With RC sub-
strates, WT mitochondria and to a much lower extent NARP mi-
tochondria were able to take up Ca
2+, whereas ρ
0, COX, CYTB, 
and MERRF mitochondria were not, as shown in the representa-
tive traces from WT and ρ
0 mitochondria (Fig. 7, A and B). How-
ever, when the mitochondria were forced to hydrolyze ATP to 
generate ∆Ψm, WT, COX, and CYTB mitochondria were able to 
take up Ca
2+, whereas ρ
0, MERRF, and NARP mitochondria 
were not (unpublished data). In summary, WT mitochondria can 
use both RC- and ATP hydrolysis–driven ∆Ψm for acute Ca
2+ 
uptake, ρ
0 and MERRF mitochondria cannot take up Ca
2+ by 
either mechanism, NARP mitochondria display a limited ability 
to take up Ca
2+ using the RC, and COX and CYTB mitochondria 
can take up Ca
2+ but only by expending ATP.
As described in the previous paragraph, only WT and 
NARP cells were able to use RC substrates to generate ∆Ψm 
(Fig. 3 A). To further study how the modality of ∆Ψm genera-
tion correlates with the Ca
2+ uptake, we measured the ability 
of isolated mitochondria to generate ∆Ψm using ATP as a sub-
strate. WT, COX, CYTB, and to a smaller extent NARP and 
MERRF cells were able to generate ∆Ψm under these condi-
tions (Fig. 7, C and D).
Collectively, these observations show that there is a corre-
lation between generation of ∆Ψm and the ability to take up Ca
2+ 
by mitochondria. This correlation is refl  ected in the sensitivity to 
TG-induced apoptosis, with the exception of NARP cells. Cells 
that generate no or low ∆Ψm (ρ
0 and MERRF) have no Ca
2+ up-
take and are protected against apoptosis. Cells that are able to 
generate ∆Ψm (WT, COX, and CYTB) do uptake Ca
2+ and can 
Figure 6.  Acute mitochondrial Ca
2+ uptake upon ER stress does 
not correlate with the pattern of ER stress–induced apoptosis. 
(A and B) Representative traces of ﬂ  uorometric measurement 
of cytosolic Ca
2+ levels are shown using the Ca
2+-sensitive 
dye Fura 2AM. Mitochondrial Ca
2+ stores were released with 
FCCP and ER calcium stores were released by the addition 
of TG. The amount of Ca
2+ in mitochondria was measured 
before (A, mCa before) and after ER calcium release with TG 
(B, mCa after). (C) Quantiﬁ   cation of mitochondrial Ca
2+ 
uptake after TG treatment. The amount of Ca
2+ taken up by 
mitochondria in the mtDNA mutant cell lines after Ca
2+ re-
lease by the ER was quantiﬁ  ed by measuring the difference 
between mCa after and mCa before.JCB • VOLUME 179 • NUMBER 6 • 2007  1170
mount a normal or high apoptotic response. However, the NARP 
cybrids represent an exception because they are only able to gen-
erate a modest ∆Ψm (Figs. 3 A and 7 D) and uptake very low 
Ca
2+ in isolated mitochondria and none in whole cells (Fig. 6 C), 
and yet they are highly sensitive to TG (Fig. 2 C). Therefore, the 
results in NARP cells  support the conclusion that in these cells 
the sensitivity to ER stress–induced apoptosis cannot be ascribed 
exclusively to acute mitochondrial Ca
2+ uptake.
Free radical production is increased in 
NARP cells in response to ER stress
We have previously demonstrated that NARP cells have in-
creased production of reactive oxygen species (ROS) under nor-
mal growth conditions (Mattiazzi et al., 2004). Increased ROS 
have also been associated with enhanced apoptosis in NARP 
fi  broblasts, which could be prevented by antioxidants (Geromel 
et al., 2001). We measured ROS production in cybrids before 
Figure 7.  Mitochondrial Ca
2+ uptake correlates with the ability to maintain 𝖫𝖿m. (A) Representative trace of Ca
2+ uptake in isolated WT mitochondria. 
100 μg mitochondria were incubated in buffer containing Calcium Green-5N, 7 mM pyruvate, and 1 mM of the RC substrate malate. Mitochondria were 
challenged with sequential additions of 100 nmol CaCl2 (arrows). After each addition there is a spike in ﬂ  uorescence caused by increase Ca
2+ concentra-
tion in the buffer. The downward slope reﬂ  ects mitochondrial uptake of Ca
2+. Note that under these conditions, WT mitochondria undergo permeability 
transition as indicated by release of Ca
2+ in the buffer. (B) Representative trace of lack of Ca
2+ uptake in isolated mitochondria from ρ
0 cells. In comparison 
to A, it is clear that there is no progressive mitochondrial Ca
2+ uptake, but the ﬂ  uorescence increases stepwise because of increased concentration of Ca
2+ 
in the buffer. (C) Representative traces of the ATP-supported ∆Ψm generation in WT and ρ
0 mitochondria. ∆Ψm supported by ATP hydrolysis was taken as 
the difference between the maximal signal generated with the addition of ATP and the minimal signal generated with the addition of carboxyatractylate (C). 
(D) Quantiﬁ  cation of ∆Ψm generated by ATP hydrolysis in cybrid cell lines (n = 3). WT, COX, CYTB, MERRF, and NARP mitochondria were able to gener-
ate ∆Ψm using ATP as a substrate, whereas ρ
0 mitochondria were not. (E) ROS production before and after stimulation with 1 μM TG. Hydroperoxides 
measured with H2DCFDA are expressed as ﬂ  uorescence units per micrograms of cellular proteins. NARP and CYTB cells have signiﬁ  cantly increased ROS 
at 18 and 24 h after TG. Error bars represent SEM.THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1171
and after treatment with STS or TG and confi  rmed that baseline 
ROS production was increased in NARP cells. However, after 
STS treatment, no signifi  cant increase in ROS was observed in 
any of the cell lines (unpublished data), whereas TG induced a 
dramatic fourfold increase in ROS production in NARP cybrids 
(Fig. 7 E). Among the other cybrid lines, only CYTB showed a 
signifi  cant ROS elevation in response to TG, but to a much 
lesser extent than NARP. These results suggest that ROS pro-
duction could be a major contributor to the increased sensitivity 
of NARP cells to ER stress–induced apoptosis.
The mitochondrial RC is required to mount 
a normal apoptotic response to ER stress
Despite the fact that all of our mtDNA mutant lines have an 
impaired RC, our data clearly indicate that there are differences 
among the mutants in the way mitochondria attempt to maintain 
∆Ψm and in Ca
2+ handling. Therefore, we hypothesized that 
such differences could be the result of changes in RC composition. 
Blue native (BN) gel electrophoresis followed by immunoblotting 
with RC-specifi  c antibodies was used to study RC assembly. 
As expected, ρ
0 cells, which lack mtDNA, did not have assem-
bled complexes I, III, IV, and V, as all of these complexes 
include mtDNA-specifi  ed subunits (Fig. 8 A). ρ
0 cells only re-
tained assembled complex II, which is entirely encoded by the 
nuclear genome. MERRF cells, which have a severe mitochon-
drial protein synthesis defect, also lacked detectable amounts of 
mtDNA-encoded complexes. Note that MERRF cells must have 
a small proportion of residual RC, below the level of detection 
by BN-Western blot, because they are capable of low-level 
oxygen consumption (Fig. 1 B) and ATP hydrolysis (Fig. 7 D). 
In COX cells, complex IV was absent and complex I was reduced, 
as previously reported (D’Aurelio et al., 2006), but complexes 
II, III, and V were present (Fig. 8 A). CYTB cells revealed a 
complete loss of complex III and a concomitant severe reduc-
tion in complex I (Acin-Perez et al., 2004), but had fully assem-
bled complexes II, IV, and V. Finally, NARP cells had all of the 
respiratory components assembled.
The pattern of RC assembly correlates with mitochondrial 
bioenergetics. Because COX and CYTB mutants lack critical 
complexes for electron fl  ux but retain complex V, their mito-
chondria can only generate ∆Ψm by ATP hydrolysis. ρ
0 and 
MERRF cells lack the RC and electron fl  ux and therefore are 
unable to generate ∆Ψm either by respiration or ATP hydrolysis. 
NARP cells, which have a functional impairment of ATPase re-
sulting in an upstream reduction of electron fl  ux and increased 
ROS production (Mattiazzi et al., 2004), have an impairment  in 
both mechanisms despite having an assembled RC.
Collectively, our data suggest that the presence of an as-
sembled RC is required to mount a normal apoptotic response. 
However, when some RC components are present but the electron 
fl  ux is disrupted, cells have increased sensitivity to ER stress–
induced apoptosis.
The RC regulates levels of antiapoptotic 
proteins at the mitochondria
It is well established that the Bcl-2 family of proteins is impor-
tant in modulating apoptosis (Danial and Korsmeyer, 2004). 
It has previously been reported that cells with mtDNA depletion 
have increased expression of the antiapoptotic protein Bcl-2 
(Biswas et al., 2005b). We confi  rmed this fi  nding in enriched 
Figure 8.  BN gels of RC complexes and mitochondrial levels of anti-
apoptotic Bcl-2 proteins. (A) WT cells have a full complement of RC 
complexes, whereas ρ
0 and MERRF cells lack assembled complexes 
containing mtDNA-speciﬁ  ed subunits (complexes I, III, IV, and V) and 
have partially assembled complex V intermediates. COX cells lack 
complex IV and have reduced complex I. CYTB cells lack complex III 
and also have severely reduced complex I. NARP cells contain all ﬁ  ve 
RC complexes. (B) Western blot of the antiapoptotic proteins Bcl-2 
and Bcl-XL in enriched mitochondrial fractions. Hsp60 was used as a 
marker of the mitochondrial matrix, Tim23 was used as a marker of 
the mitochondrial inner membrane, and VDAC was used as a marker 
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mitochondrial fractions from ρ
0 cells, which had increased Bcl-2 
as compared with WT (Fig. 8 B). Interestingly, we also found 
that MERRF cells had a similar increase in mitochondrial Bcl-2. 
This suggests that, rather than the loss of mtDNA, the signal 
that triggers Bcl-2 up-regulation is the absence of the RC itself 
because MERRF cells have normal mtDNA content but are un-
able to synthesize RC complexes. We also found that COX cells 
had decreased Bcl-XL, NARP cells had decreased Bcl-2, and 
CYTB cells had a decrease in both antiapoptotic proteins. Thus, 
cells with a defective RC and impaired electron fl  ux have dys-
regulated mitochondrial levels of antiapoptotic proteins. These 
fi  ndings suggest that the structure and function of the electron 
transport chain affects the complement of antiapoptotic pro-
teins at the mitochondria. However, if Bcl-2 was the only player 
involved, the responses to ER and mitochondrial stressors should 
follow similar patterns. Instead, we observe opposite trends 
in COX and CYTB mutants (Fig. 2). Therefore, Bcl-2 alone 
cannot explain the different sensitivity in response to the various 
apoptotic stimuli.
Electron ﬂ  ux through the RC is protective 
against ER stress–induced apoptosis
To directly assess the contribution of electron fl  ux to ER   
stress–induced apoptosis, cells were treated with FCCP in 
combination with TG. Uncoupling with FCCP allows the RC 
to transfer electrons at its maximal capacity, as shown by the 
increase in oxygen consumption in respiration-competent cells 
(Fig. 1 B), because it dissociates the demands of the ATP syn-
thase from RC activity. In WT and NARP cells, FCCP treatment 
was protective, which is consistent with the hypothesis that 
increasing electron fl  ux through the RC is protective against 
ER stress–induced apoptosis. This treatment had no effect in 
the remaining mutants as they do not have electron transfer 
capacity (Fig. 9 A).
Figure 9.  Electron ﬂ  ux through mitochondrial RC modu-
lates ER stress–induced apoptosis. (A) Caspase 3 activation 
in response to TG and FCCP. Cells were pretreated with 
5 μM FCCP for 30 min and then cotreated with 1 μM TG 
for 24 h. The effect of FCCP on TG-induced caspase 3 acti-
vation is expressed as a percentage of protection as com-
pared with the TG treatment alone (n  = 4; error bars 
represent SEM). (B) Caspase 3 activation in response to 
TG and TMPD. Cells were pretreated with 140 μM TMPD 
for 30 min and then cotreated with 1 μM TG for 24 h. 
Caspase 3 activity in WT cells treated with both TG and 
TMPD is deﬁ  ned as 100% (n = 4; error bars represent SEM). 
(C) Caspase 3 activity in untreated or 1-μM TG-treated WT 
cells with or without the addition of 100 nM of RC inhibitor 
rotenone, 4 μM of RC inhibitor piericidin A, and 1 μM of 
RC inhibitor antimycin A for 24 h. Caspase 3 activity is ex-
pressed as a percentage of WT cells treated with TG alone 
(set at 100%; n = 3; error bars represent SEM). All inhibi-
tors of the RC enhance the apoptotic response in WT cells.THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1173
COX and CYTB cells possess partially assembled RCs 
(Fig. 8 A) but have no electron fl  ux. We reasoned that these 
cells are more sensitive to ER stress because the lack of electron 
fl  ux forces the residual complexes into perpetually reduced 
states. Therefore, to reestablish the cycle of oxidation and reduc-
tion in the remaining complexes, we treated mutant cells with 
N,N,N
′,N
′-tetramethyl-P-phenylenediamine (TMPD), a redox 
mediator that can accept electrons from reduced RC complexes 
thereby restoring electron fl  ux. The optimal dose of TMPD was 
determined in CYTB mutant cells by titrating the compound 
to the minimal concentration necessary to achieve the maximal 
KCN-sensitive respiration (unpublished data).
When TMPD was administered in combination with TG, 
the levels of caspase activation in COX and CYTB cells were 
normalized to those observed in WT cells (Fig. 9 B). As ex-
pected, ρ
0, MERRF, WT, and NARP cells were unaffected by 
TMPD because ρ
0 and MERRF cells do not have RCs, whereas 
WT and NARP cells transfer electrons independent of TMPD. 
Thus, this experiment confi  rmed that stimulation of electron 
fl  ux is protective against ER stress–induced apoptosis.
Finally, we treated WT cells with the RC inhibitors rote-
none, piericidin A, and antimycin A in combination with TG. 
Rotenone and piericidin A inihibit complex I, whereas anti-
mycin A inhibits complex III. Pharmacological inhibition of 
the RC in WT cells mimics the loss of electron fl  ux in the 
presence of RC complexes, which is biochemically analogous 
to the COX, CYTB, and NARP mutants. If loss of electron 
fl  ux is proapoptotic, then RC inhibition should sensitize WT 
cells to TG. Indeed, the combined treatment of TG with either 
rotenone, piericidin A, or antimycin A resulted in increased 
apoptosis as compared with TG alone, whereas RC inhibitors 
alone had no effects (Fig. 9 C). This result is a further confi  r-
mation of the role of electron fl  ux in modulating ER stress–
induced apoptosis.
Discussion
In this study, we provide evidence that the mitochondrial RC 
regulates apoptosis in a context-dependent manner (Fig. 10). 
In the case of ER stress–induced apoptosis, blockage of the elec-
tron fl  ux caused by partial damage to the RC (COX and CYTB 
cells) strongly sensitizes cells, whereas a complete absence 
of electron fl  ux caused by lack of RC (ρ
0 and MERFF cells) 
strongly protects cells (Fig. 2, C and D). Instead, in the case of 
mitochondria-initiated apoptosis, both the partial (COX and 
CYTB cells) and complete (ρ
0 and MERFF cells) loss of RC 
protects cells from apoptosis (Fig. 2, A and B). These results in 
RC-defi  cient cells are in line with previous papers that showed 
protection against mitochondrial stressors in cells lacking 
mtDNA (Dey and Moraes, 2000; Lee et al., 2004; Park et al., 
2004). Counterintuitively, NARP cells display heightened apop-
totic responses to both the ER and mitochondrial stressors. 
In this case, the increased response to ER stress is likely to be 
ascribed to the enhanced ROS production (Fig. 7 E), whereas 
the increased response to mitochondrial stress can be ascribed 
to having a partial reduction in the electron fl  ux while still 
being capable of limited RC-dependent energy production and 
oxidative phosphorylation. Therefore, our results indicate that 
it is not the energy production impairment per se, but rather 
the interplay between the stressor and a specifi  c damage to 
individual components of the RC that modulate the strength 
of the apoptotic responses. Importantly, these patterns of re-
sponse were confi  rmed in both cybrids derived from a different 
cell type (HeLa) as well as in rederived osteosarcoma cybrids 
(Fig. S3), suggesting that these responses are not limited to spe-
cifi  c cell lines.
One possible explanation of how RC dysfunction is trans-
lated into global cellular effects is mitochondria-to-nucleus 
retrograde signaling. It has been shown that mtDNA deple-
tion alters the transcriptional profi  le of cells, e.g., elevated ex-
pression of Bcl-2, Bax, Bid, and Bad (Biswas et al., 2005b), and 
is resistant to both STS- (Biswas et al., 2005a) and ET-mediated 
(Biswas et al., 2005b) cell death. Our data also show that ρ
0 
cells have increased levels of Bcl-2 and are also resistant to STS 
and ET-mediated cell death. However, as an extension to those 
studies, we found that MERRF cells have increased Bcl-2, sug-
gesting that the RC, and not the loss of mtDNA itself, is part 
of the signal that activates the mitochondria-to-nucleus stress 
response pathway. Furthermore, we fi  nd that cell lines with 
disrupted electron fl  ux, such as COX, CYTB, and NARP, have 
dysregulated levels of Bcl-2 antiapoptotic proteins. Thus, this 
is an example of how the RC and electron fl  ux cooperate to 
regulate the mitochondrial stress response. However, we rea-
soned that if Bcl-2 proteins were the only factors involved in 
regulating apoptosis, the differences in the patterns of response 
to ER and mitochondrial stress among the mutants could not 
be explained.
Figure 10.  Correlation between RC composition and apoptotic responses 
in mtDNA mutant cybrids. The RC components of the cybrids are depicted. 
WT cells have a full complement of RC complexes. ρ
0 cells are missing 
complexes I, III, IV, and V. COX cells are missing complex IV and have re-
duced complex I (depicted as a smaller circle). CYTB cells are missing 
complex III and have reduced complex I. MERRF cells are missing com-
plexes I, III, IV, and V, detectable by BN gel, but have some residual ATP 
hydrolytic complex V activity. NARP cells have all of the complexes in 
place, but have reduced amounts and activities. Normal response to apop-
tosis induction is represented by +, high response by +++, and low 
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In our genetic model of RC dysfunction, mitochondrial 
morphological changes may also play a role in modulating the 
apoptotic response. Mitochondrial fusion and fi  ssion have been 
implicated in regulating apoptosis (Arnoult, 2007). For example, 
fragmentation of the mitochondrial network has been described 
in STS- (Karbowski et al., 2002) and ceramide-mediated (Pinton 
et al., 2001) apoptosis. Furthermore, upon STS treatment, Drp1, 
a dynamin-related protein that mediates mitochondrial outer 
membrane fi  ssion, translocates to mitochondria and a dominant-
negative Drp1 blocks the progression of STS-induced apoptosis 
(Frank et al., 2001), suggesting that the mitochondrial fi  ssion 
machinery must be engaged for apoptosis to occur. Further-
more, down-regulation of mitochondrial fi  ssion prevents the 
release of cytochrome c, possibly because of the retention of 
soluble OPA1 (Estaquier and Arnoult, 2007), a mitochondrial 
fusion protein that has been shown to maintain the integrity 
of intracristae regions (Cipolat et al., 2006; Frezza et al., 2006) 
where cytochrome c is sequestered (Scorrano et al., 2002; Frezza 
et al., 2006).
The links between the RC, the mitochondrial remodeling 
machinery, and apoptosis are not yet fully understood. It has 
been shown that ∆Ψm is required to maintain normal mitochon-
drial morphology (Legros et al., 2002) and that ρ
0 cells have 
fragmented mitochondrial networks (Gilkerson et al., 2000). 
Consistently, we show that ρ
0, COX, CYTB, and MERRF cells, 
which are unable to generate RC-driven ∆Ψm, have highly frag-
mented mitochondria (Fig. 3). Therefore, it could be speculated 
that cells with already fragmented mitochondria are protected 
because they are unable to normally engage the mitochondrial 
fi  ssion machinery upon apoptotic stimuli targeting the mitochon-
drial pathway. In addition, mitochondrial morphological changes 
may affect the way that the mitochondrial and ER networks 
interact. It is well known that these two organelles interact at 
specifi  c contact points that are likely involved in mitochondrial–
ER communication, including Ca
2+ transfer (Csordas et al., 2006; 
Szabadkai et al., 2006).
How can the mitochondrion integrate environmental sig-
nals to mediate such a wide variety of responses? Our observa-
tions suggest that ∆Ψm and RC electron fl  ux may be the key 
regulators. Accordingly, we found that stimulation of electron 
fl  ux by mitochondrial uncouplers (FCCP) or electron redox 
mediators (TMPD) protected cells against ER stress–induced 
apoptosis, whereas electron fl  ux inhibition (rotenone, piericidin A, 
and antimycin A) sensitized them (Fig. 9). The effect of mito-
chondrial uncouplers on mitochondria-initiated apoptosis in 
WT cells has been tested previously. A delay was observed in 
caspase activation by administering FCCP before the apoptotic 
stimulus (Stoetzer et al., 2002), but this effect was overcome 
if the proapoptotic stimulus was suffi  ciently prolonged (Lim 
et al., 2001), suggesting that deenergization and mitochondrial 
fragmentation are protective, but not completely preventive, 
of apoptosis.
Clearly, more work remains to be done to better under-
stand the ramifi  cations of this regulation at the molecular level 
and many potential pathways could be hypothesized for future 
investigation. As mentioned in the previous paragraph, ∆Ψm 
and electron fl  ux have local effects on mitochondrial structure, 
ROS production, and the components implicated in initiation of 
apoptosis. At the same time, they have long-ranging effects on 
extramitochondrial targets, such as the mitochondria-to-nucleus 
stress response. The latter may be performed through diffus-
ible molecules, such as free radicals, that have known signal-
ing functions.
Mitochondrial dysfunction and dysregulation of apoptosis 
have been implicated in many diseases ranging from neurode-
generation to cancer. In light of our fi  ndings, mitochondrial RC 
dysfunction may indeed have an important role in different dis-
ease conditions but its impact on cell survival cannot be pre-
dicted a priori. We suggest that the type of RC dysfunction will 
determine the predisposition toward either cell death or cell sur-
vival, depending on the environmental cues. For example, the 
Warburg theory proposes that mitochondrial defects may favor 
tumorigenesis by stimulating a glycolytic switch in metabolism 
and allowing survival under hypoxic conditions (Warburg, 
1956). However, our data on different types of mtDNA muta-
tions and cell death paradigms show that not all mtDNA muta-
tions are created equal and that a simplistic model may not always 
hold true.
MtDNA mutations and RC dysfunction have also been as-
sociated with numerous degenerative conditions, including neuro-
degeneration and aging. In many of these conditions, cell death 
has been directly attributed to mitochondrial energy depletion. 
However, our data suggest that other factors, such as modula-
tion of apoptosis, may be involved and that mtDNA mutations 
may not always have a negative impact on cell survival.
Importantly, the fi  nding that manipulation of electron fl  ux 
in a defective RC can modify the cell fate may lead the way to-
ward a better understanding of the complex involvement of mi-
tochondria in regulating cell life and death decisions. We suggest 
that a careful analysis of the association between the type of RC 
dysfunction and disease conditions should allow for a better un-
derstanding of disease pathogenesis and more effective choices 
in developing adequate therapeutic strategies.
Materials and methods
Reagents
All reagents used were purchased from Sigma-Aldrich unless otherwise 
speciﬁ  ed.
Cell culture
Human osteosarcoma (143B) transmitochondrial cybrid cell lines were cul-
tured in DME containing 4.5 g/liter of high glucose and supplemented with 
5% FBS, 1 mM sodium pyruvate, and 50 μg/ml uridine. Cytochrome b mu-
tant cells were provided by I.F. De Coo (Erasmus Medical Centre,   Rotterdam, 
The Netherlands). HeLa transmitochondrial cybrid cell lines were cultured in 
DME (Invitrogen) containing 4.5 g/liter of high glucose and supplemented 
with 10% FBS, 1 mM sodium pyruvate, and 50 μg/ml uridine.
Generation of cybrid cell lines
Cybrid cell lines with a HeLa nuclear background were established 
by chemical enucleation. The mitochondrial donor cells containing the 
mtDNA genotype of interest were chemically enucleated by treatment with 
0.5 μg/ml actinomycin D and then fused with HeLa ρ
0 cells as previously 
described (Bayona-Bafaluy et al., 2003). After fusion, cells were trans-
ferred to selection media lacking uridine to eliminate HeLa ρ
0 cells. Cybrid 
lines with the 143B nuclear background were also rederived using the 
method described for HeLa cells, except that ρ
0 143B TK cells were used 
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Oxygen consumption
The rate of oxygen consumption was measured using a Clarke-type elec-
trode (Hansatech) as previously described (D’Aurelio et al., 2001). To 
measure coupled respiration, 1.5 × 10
6 cells were resuspended in 300 μl 
glucose and FBS-free DME supplemented with 1 mM sodium pyruvate. Un-
coupled respiration was assessed with the addition of 1 μM FCCP and res-
piration was inhibited with 1.5 mM KCN.
Apoptosis assays
To induce apoptosis, cells were subjected to one of the following treat-
ments: 1 μM STS for 6 h, 10 μM ET for 24 h, 1 μM TG for 24 h, or 1 μM 
TN for 24 h.
Caspase 3 activity was measured using the caspase 3 ﬂ  uorogenic 
substrate Ac-DEVD–7-amino-4-triﬂ   uormethyl coumarin (AFC; BD Biosci-
ences). Cells were detached, washed two times with ice-cold PBS, resus-
pended in 200 μl of ice-cold lysis buffer (50 mM Hepes, pH 7.4, 10 mM 
Chaps, 5 mM DTT, 150 mM NaCl, and 1 mM PMSF), and lysed on ice for 
20 min. Lysates were centrifuged for 10 min at 16,000 g and the superna-
tant was retained. 10 μl of the supernatant was incubated with 100 μl of 
reaction buffer (50 mM Hepes, pH 7.4, 0.25% Chaps, 150 mM NaCl, 
10% sucrose, 5 mM DTT, and 0.05 mg/ml Ac-DEVD-AFC) for 1 h at 37°C. 
Ac-DEVD-AFC ﬂ  uorescence was monitored using a plate reader (HTS7000; 
PerkinElmer) with excitation at 400 nm and emission at 485 nm, and read-
ings were expressed as ﬂ  uorescence per microgram of protein.
To count apoptotic nuclei, cells were plated on glass coverslips, 
treated with the various apoptosis inducing agents, ﬁ  xed with 4% parafor-
maldehyde for 15 min, and stained with 1 μg/ml HOECHST 33342 (Invit-
rogen) diluted in PBS for 5 min. Nuclear morphology was assessed by 
ﬂ  uorescence microscopy to determine the proportion of cells with apoptotic 
(i.e., fragmented and/or condensed) nuclei.
To detect cells undergoing apoptosis, cells were stained using the 
Annexin-V-FLUOS staining kit (Roche) as per the manufacturer’s instructions 
and evaluated by ﬂ  uorescence microscopy. The proportion of apoptotic 
cells was determined by counting cells that stained positive for annexin V 
(excitation 488 nm; emission 518 nm) and negative for propidium iodide 
(excitation 488 nm; emission 617 nm), whereas necrotic cells stained posi-
tive for both annexin V and propidium iodide.
Cell viability assays
A WST-1 cell proliferation reagent (Roche) was used to measure cell 
  viability after treatment with proapoptotic compounds. Cells were plated 
onto 96-well plates in triplicates, allowed to attach for 8 h, and then sub-
jected to treatment with 1 μM STS for 3.5 h, 10 μM ET for 24 h, or 1 μM 
TG for 24 h. 20 μl WST-1 was added to each well and incubated for 2 h 
at 37°C. Changes in WST-1 absorbance were measured at 450 nm in a 
plate reader.
Free radical production
Free radical production was measured using 2’,7’-dichloroﬂ   uorescin 
di  acetate (H2DCFDA; Invitrogen). Cells were grown in 48-well plates, 
loaded with 20 μM H2DCFDA for 2 h at 37°C, and then lysed with 0.2% 
Triton X-100. H2DCFDA ﬂ  uorescence was measured in a HTS7000 plate 
reader (excitation 485 nm; emission 535 nm). Free radical production 
was expressed as the ﬂ  uorescence normalized by the protein content of 
the sample.
Confocal microscopy and image analysis
For confocal microscopy, cells were grown in 4-well chambers, stained 
with 100 nM MitoTracker Red CMXRos (Invitrogen) for 30 min at 37°C, 
and washed three times with PBS. Cells were imaged in PBS at room tem-
perature using a laser-scanning confocal microscope (LSM 510; Carl Zeiss, 
Inc.) with a 63× Plan Apochromat oil immersion lens with aperture 1.4 us-
ing a photomultiplier (Carl Zeiss, Inc.). The excitation wavelength for Mito-
Tracker Red CMXRos was 488 nm. A series of z-sections were taken 
spanning the thickness of the cell with intervals between sections set at 
0.5 μm. Z-stack images were projected onto a single plane using the LSM 
Image Browser software (Carl Zeiss, Inc.). Digital magniﬁ  cation was 2× 
(total magniﬁ  cation was 126×). Image analysis and mitochondrial length 
measurements were performed on the projected images using Metamorph 
software (MDS Analytical Technologies).
Measurements of cellular ATP content
Cellular ATP content was measured using the Enliten rLuciferase/Luciferin 
Reagent (Promega). Cells were seeded on 96-well plates and grown over-
night. Luminescence was measured according to the manufacturer’s protocol 
in a luminometer (MGM Instruments). A standard curve was constructed 
with known ATP concentrations ranging from 100 pico M to 1 mM.
Cytosolic Ca
2+ measurements in intact cells
Cytosolic Ca
2+ levels were monitored using the ﬂ  uorescent ratiometric dye 
Fura 2AM (Invitrogen). Ca
2+-free incubation buffer was composed of 145 
mM NaCl, 2.8 mM KCl, 2 mM MgCl2, 10 mM glucose, and 10 mM 
Hepes, pH 7.4. Cells were trypsinized and resuspended in incubation 
buffer at a concentration of 10
6 cells/ml and loaded with 5 μM Fura 2AM 
for 30 min at room temperature. Cells were then washed with incubation 
buffer and resuspended at a concentration of 3 × 10
5 cells/ml in Ca
2+ 
reaction buffer (2 mM CaCl2, 145 mM NaCl, 2.8 mM KCl, 2 mM MgCl2, 
10 mM glucose, and 10 mM Hepes, pH 7.4). Fura 2AM ﬂ  uorescence was 
measured in a ﬂ  uorimeter cuvette with constant stirring, and recorded at 
340/380 nm excitation and 512 nm emission with a ﬂ  uorescence spectro-
photometer (F-4500; Hitachi). Ca
2+ was released from the ER using 1 μM 
TG and from mitochondria using 2.5 μM FCCP. The ratio of Fura 2AM 
ﬂ  uorescence was plotted against time.
Ca
2+ uptake in isolated mitochondria
Ca
2+ uptake was measured in enriched mitochondrial fractions using the 
dye Calcium Green-5N (Invitrogen). Enriched mitochondrial fractions 
were prepared by harvesting cells in MS-EGTA buffer (225 mM mannitol, 
75 mM sucrose, 5 mM Hepes, and 1 mM EGTA, pH 7.4, with KOH), homo-
genization with a Dounce homogenizer, and differential centrifugation. 
Homogenate was ﬁ  rst centrifuged at 2,000 g for 5 min at 4°C. The super-
natant was then centrifuged at 14,000 g for 10 min at 4°C. The resulting 
mitochondrial pellet was kept on ice. Mitochondria were incubated in KCl 
buffer (125 mM KCl, 20 mM Hepes, 2 mM MgCl2, 2 mM potassium phos-
phate, and 40 μM EGTA, pH 7.2, with KOH) containing 200 nM Calcium 
Green-5N and either 1 mM pyruvate and 7 mM malate or 4 mM ATP. 
Mitochondria were challenged with sequential CaCl2 additions and cal-
cium uptake was monitored in a ﬂ  uorescence spectrophotometer.
𝖫𝖿m
The ability to generate ∆Ψm was assessed in enriched mitochondrial frac-
tions using the dye safranin-O as previously described (Akerman and 
  Wikstrom, 1976; Kowaltowski et al., 2002) with modiﬁ  cations. Enriched 
mitochondrial fractions were prepared by harvesting cells in MS-EGTA buf-
fer and homogenizing using a dounce homogenizer. Cell homogenate was 
ﬁ  rst centrifuged at 600 g for 5 min to pellet nuclei and unbroken cells. The 
supernatant was then removed and centrifuged at 10,000 g for 10 min to 
pellet mitochondria. The mitochondrial pellet was resuspended in MS-
EGTA buffer. Mitochondria were incubated with safranin-O at a ratio of 
20:1 (dye/mitochondrial protein; Zanotti and Azzone, 1980) in 1 ml KCl 
buffer. Safranin-O ﬂ  uorescence was monitored in a ﬂ  uorimeter cuvette with 
constant stirring and recorded at 485 nm excitation and 586 nm emission. 
2 mM ATP was added to the reaction to measure the ATP hydrolysis–
supported ∆Ψm. Where indicated, mitochondria were deenergized by inhibit-
ing the ADP–ATP exchange with 1.3 μM carboxyatractylate, a speciﬁ  c 
inhibitor of the adenine nucleotide transporter. To assess the RC-dependent 
generation of ∆Ψm, the incubation medium was supplemented with 5 mM 
succinate. Where indicated, mitochondria were deenergized by blocking 
the electron transport at RC complex III with 1 μM of its speciﬁ  c inhibitor 
antimycin A.
BN gels
BN PAGE followed by immunodetection was used to identify individual RC 
complexes. Mitochondrial membranes were prepared by permeabilizing 
2.5 × 10
6 cells with 0.2% wt/vol digitonin (Sigma-Aldrich) for 10 min on 
ice as previously described (Nijtmans et al., 2002). 10 μl of sample were 
loaded on a 5–13% gradient polyacrylamide gel and electrophoresis was 
performed as previously described (Nijtmans et al., 2002). Transfer of pro-
teins onto polyvinylidine ﬂ  uoride (PVDF) membrane (Bio-Rad Laboratories) 
was performed overnight at 30 V at 4°C. For immunodetection of the pro-
tein complexes, monoclonal antibodies (Invitrogen) against the following 
RC complexes were used: the 39-kD subunit of complex I, the 70-kD sub-
unit of complex II, the core 2 subunit of complex III, subunit I of complex IV, 
and the β subunit of complex V.
Western blotting
For Western blots of total cellular protein, cells were lysed on ice with 
25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-40, and 1% sodium 
deoxycholate, and 0.1% SDS and protein concentrations were measured 
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and transferred to PVDF membranes. Membranes were then blocked with 
5% nonfat milk in 0.1% TBS–tween 20 and probed with speciﬁ  c antibodies 
(BD Biosciences) against Grp78 (1:250), Tim23 (1:5,000), caspase 3 
(1:1,000), and caspase 9 (1:1,000).
For Western blots of enriched mitochondrial fractions prepared by 
subcellular fractionation and differential centrifugation, 10
7 cells were tryp-
sinized and washed in ice-cold NKM buffer (130 mM NaCl, 5 mM KCl, 
and 7.5 mM MgCl2). Cells were then resuspended in RSB buffer (10 mM 
Tris-HCl, pH 7.6, 10 mM KCl, and 0.15 mM MgCl2) and swelled for 4 min 
on ice before homogenization with a glass Dounce homogenizer. Sucrose 
was then added to a ﬁ  nal concentration of 500 mM. The total cell homo-
genate was then centrifuged at 600 g for 10 min at 4°C, and the super-
natant was centrifuged at 15,000 g for 15 min at 4°C to pellet the 
mitochondria. Equal amounts of mitochondrial protein were loaded and 
resolved by electrophoresis in a 10% SDS–polyacrylamide gel, and then 
transferred to PVDF membranes. Membranes were blocked with 5% nonfat 
milk in TBS–tween 20 (0.1%) and probed with speciﬁ  c antibodies against 
Bcl-2 (1:1,000; Santa Cruz Biotechnology, Inc.), BclXL (1:1,000; Santa 
Cruz Biotechnology, Inc.), Tim23 (1:5,000; BD Biosciences), Hsp60 
(1:2,500; Assay Designs), and VDAC (1:5,000; EMD). Membranes were 
then incubated with HRP-conjugated secondary antibodies and developed 
with a chemiluminescent reagent (Thermo Fisher Scientiﬁ  c).
Online supplemental material
Fig. S1 shows percentage of apoptotic nuclei in cells treated with STS and 
cells undergoing apoptosis upon treatment with TG. Fig. S2 shows Western 
blots of caspase 9 and 3 and cell survival assays. Fig. S3 shows caspase 
3 activity in response to TG and caspase 3 activity in response to TG in 
HeLa WT and HeLa ρ
0 cells. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200704059/DC1.
This work was supported by the Muscular Dystrophy Association (G. Manfredi), 
National Institutes of Health National Institute of Neurological Disorders and 
Stroke grant K02NS047306 (G. Manfredi), and the American Federation for 
Aging Research (J.Q. Kwong).
Submitted: 11 April 2007
Accepted: 16 November 2007
References
Acin-Perez, R., M.P. Bayona-Bafaluy, P. Fernandez-Silva, R. Moreno-
Loshuertos, A. Perez-Martos, C. Bruno, C.T. Moraes, and J.A. Enriquez. 
2004. Respiratory complex III is required to maintain complex I in mam-
malian mitochondria. Mol. Cell. 13:805–815.
Akerman, K.E., and M.K. Wikstrom. 1976. Safranine as a probe of the mitochon-
drial membrane potential. FEBS Lett. 68:191–197.
Anderson, S., A.T. Bankier, B.G. Barrell, M.H. de Bruijn, A.R. Coulson, J. 
Drouin, I.C. Eperon, D.P. Nierlich, B.A. Roe, F. Sanger, et al. 1981. 
Sequence and organization of the human mitochondrial genome. Nature. 
290:457–465.
Arnoult, D. 2007. Mitochondrial fragmentation in apoptosis. Trends Cell Biol. 
17:6–12.
Bayona-Bafaluy, M.P., G. Manfredi, and C.T. Moraes. 2003. A chemical enu-
cleation method for the transfer of mitochondrial DNA to rho(o) cells. 
Nucleic Acids Res. 31:e98.
Biswas, G., H.K. Anandatheerthavarada, and N.G. Avadhani. 2005a. Mechanism 
of mitochondrial stress-induced resistance to apoptosis in mitochondrial 
DNA-depleted C2C12 myocytes. Cell Death Differ. 12:266–278.
Biswas, G., M. Guha, and N.G. Avadhani. 2005b. Mitochondria-to-nucleus stress 
signaling in mammalian cells: nature of nuclear gene targets, transcrip-
tion regulation, and induced resistance to apoptosis. Gene. 354:132–139.
Bruno, C., A. Martinuzzi, Y. Tang, A.L. Andreu, F. Pallotti, E. Bonilla, S. 
Shanske, J. Fu, C.M. Sue, C. Angelini, et al. 1999. A stop-codon mutation 
in the human mtDNA cytochrome c oxidase I gene disrupts the functional 
structure of complex IV. Am. J. Hum. Genet. 65:611–620.
Chatterjee, A., E. Mambo, and D. Sidransky. 2006. Mitochondrial DNA muta-
tions in human cancer. Oncogene. 25:4663–4674.
Cipolat, S., T. Rudka, D. Hartmann, V. Costa, L. Serneels, K. Craessaerts, K. 
Metzger, C. Frezza, W. Annaert, L. D’Adamio, et al. 2006. Mitochondrial 
rhomboid PARL regulates cytochrome c release during apoptosis via 
OPA1-dependent cristae remodeling. Cell. 126:163–175.
Cortes-Hernandez, P., M.E. Vazquez-Memije, and J.J. Garcia. 2007. ATP6 homo-
plasmic mutations inhibit and destabilize the human F1F0-ATP synthase 
without preventing enzyme assembly and oligomerization. J. Biol. Chem. 
282:1051–1058.
Csordas, G., C. Renken, P. Varnai, L. Walter, D. Weaver, K.F. Buttle, T. Balla, 
C.A. Mannella, and G. Hajnoczky. 2006. Structural and functional features 
and signifi  cance of the physical linkage between ER and mitochondria. 
J. Cell Biol. 174:915–921.
D’Aurelio, M., F. Pallotti, A. Barrientos, C.D. Gajewski, J.Q. Kwong, C. 
Bruno, M.F. Beal, and G. Manfredi. 2001. In vivo regulation of oxida-
tive phosphorylation in cells harboring a stop-codon mutation in mito-
chondrial DNA-encoded cytochrome c oxidase subunit I. J. Biol. Chem. 
276:46925–46932.
D’Aurelio, M., C.D. Gajewski, G. Lenaz, and G. Manfredi. 2006. Respiratory 
chain supercomplexes set the threshold for respiration defects in human 
mtDNA mutant cybrids. Hum. Mol. Genet. 15:2157–2169.
Danial, N.N., and S.J. Korsmeyer. 2004. Cell death: critical control points. Cell. 
116:205–219.
De Coo, I.F., W.O. Renier, W. Ruitenbeek, H.J. Ter Laak, M. Bakker, H. 
Schagger, B.A. Van Oost, and H.J. Smeets. 1999. A 4-base pair deletion 
in the mitochondrial cytochrome b gene associated with parkinsonism/
MELAS overlap syndrome. Ann. Neurol. 45:130–133.
Dey, R., and C.T. Moraes. 2000. Lack of oxidative phosphorylation and low 
mitochondrial membrane potential decrease susceptibility to apoptosis 
and do not modulate the protective effect of Bcl-x(L) in osteosarcoma 
cells. J. Biol. Chem. 275:7087–7094.
DiMauro, S., and E.A. Schon. 2003. Mitochondrial respiratory-chain diseases. 
N. Engl. J. Med. 348:2656–2668.
Estaquier, J., and D. Arnoult. 2007. Inhibiting Drp1-mediated mitochondrial fi  s-
sion selectively prevents the release of cytochrome c during apoptosis. 
Cell Death Differ. 14:1086–1094.
Frank, S., B. Gaume, E.S. Bergmann-Leitner, W.W. Leitner, E.G. Robert, F. Catez, 
C.L. Smith, and R.J. Youle. 2001. The role of dynamin-related protein 1, a 
mediator of mitochondrial fi  ssion, in apoptosis. Dev. Cell. 1:515–525.
Frezza, C., S. Cipolat, O. Martins de Brito, M. Micaroni, G.V. Beznoussenko, 
T. Rudka, D. Bartoli, R.S. Polishuck, N.N. Danial, B. De Strooper, and 
L. Scorrano. 2006. OPA1 controls apoptotic cristae remodeling indepen-
dently from mitochondrial fusion. Cell. 126:177–189.
Geromel, V., N. Kadhom, I. Cebalos-Picot, O. Ouari, A. Polidori, A. Munnich, A. 
Rotig, and P. Rustin. 2001. Superoxide-induced massive apoptosis in cul-
tured skin fi  broblasts harboring the neurogenic ataxia retinitis pigmentosa 
(NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum. 
Mol. Genet. 10:1221–1228.
Gilkerson, R.W., D.H. Margineantu, R.A. Capaldi, and J.M. Selker. 2000. 
Mitochondrial DNA depletion causes morphological changes in the mito-
chondrial reticulum of cultured human cells. FEBS Lett. 474:1–4.
Holt, I.J., A.E. Harding, R.K. Petty, and J.A. Morgan-Hughes. 1990. A new 
mitochondrial disease associated with mitochondrial DNA heteroplasmy. 
Am. J. Hum. Genet. 46:428–433.
Izyumov, D.S., A.V. Avetisyan, O.Y. Pletjushkina, D.V. Sakharov, K.W. Wirtz, 
B.V. Chernyak, and V.P. Skulachev. 2004. “Wages of fear”: transient 
threefold decrease in intracellular ATP level imposes apoptosis. Biochim. 
Biophys. Acta. 1658:141–147.
Karbowski, M., Y.J. Lee, B. Gaume, S.Y. Jeong, S. Frank, A. Nechushtan, A. 
Santel, M. Fuller, C.L. Smith, and R.J. Youle. 2002. Spatial and temporal 
association of Bax with mitochondrial fi  ssion sites, Drp1, and Mfn2 dur-
ing apoptosis. J. Cell Biol. 159:931–938.
King, M.P., and G. Attardi. 1989. Human cells lacking mtDNA: repopulation with 
exogenous mitochondria by complementation. Science. 246:500–503.
Kowaltowski, A.J., R.G. Cosso, C.B. Campos, and G. Fiskum. 2002. Effect of 
Bcl-2 overexpression on mitochondrial structure and function. J. Biol. 
Chem. 277:42802–42807.
Kujoth, G.C., C. Leeuwenburgh, and T.A. Prolla. 2006. Mitochondrial DNA mu-
tations and apoptosis in mammalian aging. Cancer Res. 66:7386–7389.
Kwong, J.Q., M.F. Beal, and G. Manfredi. 2006. The role of mitochondria in 
inherited neurodegenerative diseases. J. Neurochem. 97:1659–1675.
Lee, M.S., J.Y. Kim, and S.Y. Park. 2004. Resistance of rho(0) cells against 
apoptosis. Ann. NY Acad. Sci. 1011:146–153.
Legros, F., A. Lombes, P. Frachon, and M. Rojo. 2002. Mitochondrial fusion in 
human cells is effi  cient, requires the inner membrane potential, and is 
mediated by mitofusins. Mol. Biol. Cell. 13:4343–4354.
Li, J., B. Lee, and A.S. Lee. 2006. Endoplasmic reticulum stress-induced apop-
tosis: multiple pathways and activation of p53-up-regulated modulator of 
apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 281:7260–7270.
Lim, M.L., T. Minamikawa, and P. Nagley. 2001. The protonophore CCCP in-
duces mitochondrial permeability transition without cytochrome c release 
in human osteosarcoma cells. FEBS Lett. 503:69–74.
Mattiazzi, M., C. Vijayvergiya, C.D. Gajewski, D.C. DeVivo, G. Lenaz, M. 
Wiedmann, and G. Manfredi. 2004. The mtDNA T8993G (NARP) muta-
tion results in an impairment of oxidative phosphorylation that can be 
improved by antioxidants. Hum. Mol. Genet. 13:869–879.THE RESPIRATORY CHAIN MODULATES APOPTOSIS • KWONG ET AL. 1177
Nijtmans, L.G., N.S. Henderson, and I.J. Holt. 2002. Blue Native electropho-
resis to study mitochondrial and other protein complexes. Methods. 
26:327–334.
Park, S.Y., I. Chang, J.Y. Kim, S.W. Kang, S.H. Park, K. Singh, and M.S. 
Lee. 2004. Resistance of mitochondrial DNA-depleted cells against 
cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem. 
279:7512–7520.
Pinton, P., D. Ferrari, E. Rapizzi, F. Di Virgilio, T. Pozzan, and R. Rizzuto. 2001. 
The Ca
2+ concentration of the endoplasmic reticulum is a key determi-
nant of ceramide-induced apoptosis: signifi  cance for the molecular mech-
anism of Bcl-2 action. EMBO J. 20:2690–2701.
Polyak, K., Y. Li, H. Zhu, C. Lengauer, J.K. Willson, S.D. Markowitz, M.A. 
Trush, K.W. Kinzler, and B. Vogelstein. 1998. Somatic mutations of 
the mitochondrial genome in human colorectal tumours. Nat. Genet. 
20:291–293.
Scorrano, L., M. Ashiya, K. Buttle, S. Weiler, S.A. Oakes, C.A. Mannella, and 
S.J. Korsmeyer. 2002. A distinct pathway remodels mitochondrial cristae 
and mobilizes cytochrome c during apoptosis. Dev. Cell. 2:55–67.
Spierings, D., G. McStay, M. Saleh, C. Bender, J. Chipuk, U. Maurer, and D.R. 
Green. 2005. Connected to death: the (unexpurgated) mitochondrial path-
way of apoptosis. Science. 310:66–67.
Stoetzer, O.J., A. Pogrebniak, R. Pelka-Fleischer, M. Hasmann, W. Hiddemann, 
and V. Nuessler. 2002. Modulation of apoptosis by mitochondrial uncou-
plers: apoptosis-delaying features despite intrinsic cytotoxicity. Biochem. 
Pharmacol. 63:471–483.
Szabadkai, G., K. Bianchi, P. Varnai, D. De Stefani, M.R. Wieckowski, D. 
Cavagna, A.I. Nagy, T. Balla, and R. Rizzuto. 2006. Chaperone-mediated 
coupling of endoplasmic reticulum and mitochondrial Ca
2+ channels. 
J. Cell Biol. 175:901–911.
Wallace, D.C., X.X. Zheng, M.T. Lott, J.M. Shoffner, J.A. Hodge, R.I. Kelley, 
C.M. Epstein, and L.C. Hopkins. 1988. Familial mitochondrial encepha-
lomyopathy (MERRF): genetic, pathophysiological, and biochemical 
characterization of a mitochondrial DNA disease. Cell. 55:601–610.
Warburg, O. 1956. On respiratory impairment in cancer cells. Science. 124:269–270.
Xu, C., B. Bailly-Maitre, and J.C. Reed. 2005. Endoplasmic reticulum stress: 
cell life and death decisions. J. Clin. Invest. 115:2656–2664.
Zanotti, A., and G.F. Azzone. 1980. Safranine as membrane potential probe in rat 
liver mitochondria. Arch. Biochem. Biophys. 201:255–265.